Similar articles

• Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?

  Agnelli G. Agnelli G. Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83. Haematologica. 1995. PMID: 7628776 Review. No abstract available.
• [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].

  Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weil D, Butel J. Planes A, et al. Rev Chir Orthop Reparatrice Appar Mot. 1988;74 Suppl 2:215-8. Rev Chir Orthop Reparatrice Appar Mot. 1988. PMID: 2852830 Clinical Trial. French. No abstract available.
• Thrombo-embolism as a complication of prosthetic replacement operations of the hip: prophylaxis with heparin at low doses.

  Gnudi S, Picci P, Figus E. Gnudi S, et al. Ital J Orthop Traumatol. 1980 Apr;6(1):147-51. Ital J Orthop Traumatol. 1980. PMID: 7203996
• Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.

  Urlep-Salinović V, Jelatancev B, Gorisek B. Urlep-Salinović V, et al. Thromb Haemost. 1994 Jul;72(1):16-20. Thromb Haemost. 1994. PMID: 7974365 Clinical Trial.
• Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.

  Kakkar VV. Kakkar VV. Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19. Semin Hematol. 1997. PMID: 9399405 Review. No abstract available.